昨日-吃藥吃到想中毒

Posted On 星期四, 七月 3, 2008

Filed under My Profession, Pharmacy Knowledge
標籤:

Comments Dropped one response

首先, 我必須要說, 我所做的事情, 是不正確的, 也違背了我所學(yes, I know that)

但是, 我還是做了; 而且似乎, 副作用很大>

前幾天在Twitter發了些哭么文, 因為我身體實在是太難受了

自從被小簡傳染了之後, 先是唱爆的喉嚨中槍(可能是唱到有傷口, 易感染了吧)

唱完, 隔天, 就粉有感覺….藥發了喔!!

想不到越來越嚴重, 痰, 開始有了顏色, 也開始有了味道(我知道有點噁, 忍一下, 好嗎!?)

Shit!! 鼻子來了, 超級大過敏的鼻子的我, 開始流鼻水打噴嚏…….發出多每分鐘有幾十萬上下吧

我稱不下去啦!! 昨天坐在位子上, 根本就是如坐針氈

竟然沒有一個人看得出來我重病了, 媽的!! 胖子就不能看起來有一點點像生病嗎??

忍不住了, 所以回家吃藥………..

為啥不去看醫生呢? 第一, 因為我懶><!– 真的有那種無力感, 要把健保卡給找出來

然後還騎車到診所, 還有走路下來………我很怕麻煩, 最主要就是懶

第二, 個人喜歡自我治療, 這之前說過啦, 知道這有些不對, 但是我還是坐了

Oops!! I did it again~

OK!! 前源交代完了, 開始進入今天的正題

首先是, 我昨天晚上啃過的要!!
1. 氣舒痰錠, Bisolvon
http://drug.doh.gov.tw/medication_exterior_acts.php?type=pro&cnt_id=2195

2. 諾克過敏鼻炎膠囊
http://203.65.100.151/DO8180T.asp?Type=Lic&LicId=01022390
http://203.65.100.151/DO8180T.asp?Type=Ingr&LicId=01022390

3. “大正" 感冒膠囊
http://www.twtaisho.com.tw/products/b_01_007.htm

4. 斯斯鼻炎膠囊
http://drug.doh.gov.tw/medication_exterior_acts.php?type=pro&cnt_id=2762

5. 諾克咳嗽微粒膠囊
http://drug.doh.gov.tw/medication_exterior_acts.php?type=pro&cnt_id=3808

OK!! 我的用藥介紹完了

怎樣個吃法呢? 好, 我先認錯~ Sorry!!

上面1~5全都吃一顆, that’s it!!

我知道這是非常愚蠢的行為, 我知道這樣會有重複用藥, 我也知道這會友藥物交互作用

我都知道, 但我還是吃了~

老實說, 說老實, 我真的好很多, 根本就是到了天堂, 之前是在又黏又濕的鼻水過敏地獄

很痛苦, 很無奈, 也很無力

所以我全吞了, 還睡得頗順, 頗好的><!–

好!! 藥物交互作用………現在是事後馬後砲, 來了!! 自己揭發自己的罪行

我現在感覺到的副作用是: a. 視覺模糊; b. 頭重腳輕; c. 前額面腫脹感覺; b. 四肢稍微無力

請看, 我用Drug.com的Drug Interaction Checker

http://www.drugs.com/drug_interactions.html

所檢查出來的drug interaction有, 這樣一長串:

 

Close Print this pageDrug interaction results for the following 11 drug(s):

acetaminophen
belladonna
Bisolvon Dry (dextromethorphan)
caffeine
carbinoxamine
chlorpheniramine
glycyrrhiza (licorice)
guaifenesin
phenylephrine
phenylpropanolamine
potassium guaiacolsulfonate

Interactions between your selected drugs
phenylephrine and phenylpropanolamine (Moderate Drug-Drug)

MONITOR: Central nervous system (CNS) stimulants, particularly the amphetamines, can potentiate the adrenergic response to pressor agents. CNS stimulants often have peripheral sympathetic activity and can increase blood pressure and heart rate, thus they may have additive effects with pressor agents.

MANAGEMENT: Caution is advised if CNS stimulants are used with pressor agents. Pulse and blood pressure should be closely monitored.
chlorpheniramine and belladonna (Moderate Drug-Drug)

MONITOR: Agents with anticholinergic properties (e.g., sedating antihistamines; antispasmodics; neuroleptics; phenothiazines; skeletal muscle relaxants; tricyclic antidepressants; class IA antiarrhythmics especially disopyramide) may have additive effects when used in combination. Excessive parasympatholytic effects may result in paralytic ileus, hyperthermia, heat stroke, and the anticholinergic intoxication syndrome. Peripheral symptoms of intoxication commonly include mydriasis, blurred vision, flushed face, fever, dry skin and mucous membranes, tachycardia, urinary retention, and constipation. Central symptoms may include memory loss, disorientation, incoherence, hallucinations, psychosis, delirium, hyperactivity, twitching or jerking movements, stereotypy, and seizures. Central nervous system-depressant effects may also be additively or synergistically increased when these agents are combined, especially in elderly or debilitated patients. Use of neuroleptics in combination with other neuroleptics or anticholinergic agents may increase the risk of tardive dyskinesia.

MANAGEMENT: Caution is advised when agents with anticholinergic properties are combined, particularly in the elderly and those with underlying organic brain disease, who tend to be more sensitive to the central anticholinergic effects of these drugs and in whom toxicity symptoms may be easily overlooked. Patients should be advised to notify their physician promptly if they experience potential symptoms of anticholinergic intoxication such as abdominal pain, fever, heat intolerance, blurred vision, confusion, and/or hallucinations. Ambulatory patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them. A reduction in anticholinergic dosages may be necessary if excessive adverse effects develop.
chlorpheniramine and carbinoxamine (Moderate Drug-Drug)

MONITOR: Agents with anticholinergic properties (e.g., sedating antihistamines; antispasmodics; neuroleptics; phenothiazines; skeletal muscle relaxants; tricyclic antidepressants; class IA antiarrhythmics especially disopyramide) may have additive effects when used in combination. Excessive parasympatholytic effects may result in paralytic ileus, hyperthermia, heat stroke, and the anticholinergic intoxication syndrome. Peripheral symptoms of intoxication commonly include mydriasis, blurred vision, flushed face, fever, dry skin and mucous membranes, tachycardia, urinary retention, and constipation. Central symptoms may include memory loss, disorientation, incoherence, hallucinations, psychosis, delirium, hyperactivity, twitching or jerking movements, stereotypy, and seizures. Central nervous system-depressant effects may also be additively or synergistically increased when these agents are combined, especially in elderly or debilitated patients. Use of neuroleptics in combination with other neuroleptics or anticholinergic agents may increase the risk of tardive dyskinesia.

MANAGEMENT: Caution is advised when agents with anticholinergic properties are combined, particularly in the elderly and those with underlying organic brain disease, who tend to be more sensitive to the central anticholinergic effects of these drugs and in whom toxicity symptoms may be easily overlooked. Patients should be advised to notify their physician promptly if they experience potential symptoms of anticholinergic intoxication such as abdominal pain, fever, heat intolerance, blurred vision, confusion, and/or hallucinations. Ambulatory patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them. A reduction in anticholinergic dosages may be necessary if excessive adverse effects develop.
belladonna and carbinoxamine (Moderate Drug-Drug)

MONITOR: Agents with anticholinergic properties (e.g., sedating antihistamines; antispasmodics; neuroleptics; phenothiazines; skeletal muscle relaxants; tricyclic antidepressants; class IA antiarrhythmics especially disopyramide) may have additive effects when used in combination. Excessive parasympatholytic effects may result in paralytic ileus, hyperthermia, heat stroke, and the anticholinergic intoxication syndrome. Peripheral symptoms of intoxication commonly include mydriasis, blurred vision, flushed face, fever, dry skin and mucous membranes, tachycardia, urinary retention, and constipation. Central symptoms may include memory loss, disorientation, incoherence, hallucinations, psychosis, delirium, hyperactivity, twitching or jerking movements, stereotypy, and seizures. Central nervous system-depressant effects may also be additively or synergistically increased when these agents are combined, especially in elderly or debilitated patients. Use of neuroleptics in combination with other neuroleptics or anticholinergic agents may increase the risk of tardive dyskinesia.

MANAGEMENT: Caution is advised when agents with anticholinergic properties are combined, particularly in the elderly and those with underlying organic brain disease, who tend to be more sensitive to the central anticholinergic effects of these drugs and in whom toxicity symptoms may be easily overlooked. Patients should be advised to notify their physician promptly if they experience potential symptoms of anticholinergic intoxication such as abdominal pain, fever, heat intolerance, blurred vision, confusion, and/or hallucinations. Ambulatory patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them. A reduction in anticholinergic dosages may be necessary if excessive adverse effects develop.
acetaminophen and belladonna (Minor Drug-Drug)

Anticholinergic agents may delay and/or decrease the gastrointestinal absorption of acetaminophen by reducing gastric motility and delaying gastric emptying. However, the clinical relevance is probably minimal.
Other drugs that your selected drugs interact with
• There are 237 other drugs known to interact with acetaminophen

• There are 1146 other drugs known to interact with belladonna

• There are 107 other drugs known to interact with Bisolvon Dry (dextromethorphan)

• There are 218 other drugs known to interact with caffeine

• There are 1044 other drugs known to interact with carbinoxamine

• There are 1053 other drugs known to interact with chlorpheniramine

• There are 99 other drugs known to interact with glycyrrhiza (licorice)

• There are 345 other drugs known to interact with phenylephrine

• There are 415 other drugs known to interact with phenylpropanolamine

• There are 109 other drugs known to interact with potassium guaiacolsulfonate

Interactions between your selected drugs and food
caffeine (Minor Drug-Food)

The effect of grapefruit juice on the pharmacologic activity of caffeine is controversial. One report suggests that grapefruit juice increases the effect of caffeine. The proposed mechanism is inhibition of cytochrome P-450 metabolism of caffeine. However, a well-conducted pharmacokinetic/pharmacodynamic study did not demonstrate this effect. The clinical significance of this potential interaction is unknown.

——————————————————————————–

Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum’s drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum’s drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

 

廣告

One Response to “昨日-吃藥吃到想中毒”

  1. sinthia

    老實說…假如是我的話還寧願去給醫生打針…
    感覺會好很多,感覺也很得比較快,至少…
    在工作時也不會那麼痛苦…
    所以別逞強啦~去看個醫生吧~
    除非…你怕打針 >"<

發表迴響

在下方填入你的資料或按右方圖示以社群網站登入:

WordPress.com Logo

您的留言將使用 WordPress.com 帳號。 登出 / 變更 )

Twitter picture

您的留言將使用 Twitter 帳號。 登出 / 變更 )

Facebook照片

您的留言將使用 Facebook 帳號。 登出 / 變更 )

Google+ photo

您的留言將使用 Google+ 帳號。 登出 / 變更 )

連結到 %s